Abstract
Last month, the Office of National Drug Control Policy (ONDCP) issued a “Dear Colleagues” letter calling on personal protective equipment (PPE) suppliers to honor requests from substance use disorder (SUD) treatment providers. “Treatment providers and all others associated with maintaining this vital sector of healthcare serve in a critical capacity and will require personal protective equipment (PPE) during unavoidable face‐to‐face patient interactions,” wrote James W. Carroll, ONDCP director, in the April 23 letter.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
